Related Experiment Video
Updated: Jun 21, 2026
06:20
Cell-Free DNA Extraction of Vitreous and Aqueous Humor Specimens for Diagnosis and Monitoring of Vitreoretinal Lymphoma
Published on: January 12, 2024
Pathophysiology of retinal lymphoma.
Sarah E Coupland1, Chi Chao Chan, Justine Smith
1Department of Cellular and Molecular Pathology, University of Liverpool, Liverpool, England. s.e.coupland@liverpool.ac.uk
Ocular Immunology and Inflammation
|August 7, 2009
Summary
Retinal lymphoma is a serious eye cancer, often linked to brain involvement. Diagnosis involves cell features and markers, with research exploring better treatments.
Area of Science:
- Ophthalmology
- Hematology
- Oncology
Background:
- Retinal lymphoma is the most common intraocular malignancy, typically high-grade B-cell type.
- It carries a poor prognosis due to frequent central nervous system (CNS) involvement.
- Neoplastic B-cells exhibit distinct morphology, immunophenotype, chemokine/receptor expression, and interleukin production (e.g., IL-10).
Purpose of the Study:
- To detail the diagnostic features of retinal lymphoma.
- To explore the cellular origins and potential prognostic markers.
- To identify new therapeutic targets for this malignancy.
Main Methods:
- Cytological analysis
- Immunophenotyping
- Somatic mutation analysis
- Chromosomal translocation analysis
- Gene expression profiling (proposed)
Main Results:
- Diagnostic aids include cytological features, immunophenotype, immunoglobulin rearrangements, and biochemical profiles.
- Immunophenotyping and mutation analysis suggest origin from early post-germinal center B-cells.
- Chromosomal data indicate a subgroup may originate from germinal center B-cells, potentially with a better prognosis.
Conclusions:
- Retinal lymphoma diagnosis relies on integrated analysis of cellular and molecular features.
- Understanding B-cell origin may refine prognosis.
- Further research, including gene expression profiling, is crucial for identifying novel prognostic and therapeutic markers.
